ThermoGenesis Holdings, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. The Company operates a device and clinical division.
Informational stock graphs above displayed with B2i.
For more detailed information about ThermoGenesis stock, please the Official Nasdaq Page.
For all investor-related questions, please contact us at email@example.com.